Protected: Neoadjuvant treatment key to unlocking benefits of PBS-listed Kadcyla® (trastuzumab emtansine) in the adjuvant setting
This content is password-protected. To view it, please enter the password below. Password:
Browsing: Roche
Protected: TECENTRIQ® (atezolizumab) first immunotherapy to be reimbursed for 1L treatment of extensive-stage small cell lung cancer
This content is password-protected. To view it, please enter the password below. Password:
Protected: Immunotherapy combination now PBS listed for first-line treatment of metastatic non-squamous non-small cell lung cancer (1,2)
This content is password-protected. To view it, please enter the password below. Password:
Protected: Tecentriq® (atezolizumab) + chemotherapy now TGA approved for 1L extensive-stage small cell lung cancer
This content is password-protected. To view it, please enter the password below. Password: